Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17316120rdf:typepubmed:Citationlld:pubmed
pubmed-article:17316120lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:17316120lifeskim:mentionsumls-concept:C0549473lld:lifeskim
pubmed-article:17316120lifeskim:mentionsumls-concept:C0227391lld:lifeskim
pubmed-article:17316120lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:17316120pubmed:issue2lld:pubmed
pubmed-article:17316120pubmed:dateCreated2007-2-23lld:pubmed
pubmed-article:17316120pubmed:abstractTextPrognosis of differentiated thyroid cancer is favorable in the majority of cases. However, distant metastases occur in 10-15% of cases, predominantly in lungs and bones, especially in older patients exhibiting poorly differentiated forms or advanced stages. We report a case history of Hürthle cell thyroid carcinoma metastasized to the sigmoid colon. To the best of our knowledge, this location has never been described before. This case history illustrates the difficulties of diagnosis and treatment in patients whose metastases do not concentrate radioiodine. The interest of different imaging modalities, including fluoro-deoxy-glucose positron emission tomography scan and somatostatin receptor scintigraphy, is discussed.lld:pubmed
pubmed-article:17316120pubmed:languageenglld:pubmed
pubmed-article:17316120pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17316120pubmed:citationSubsetIMlld:pubmed
pubmed-article:17316120pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17316120pubmed:statusMEDLINElld:pubmed
pubmed-article:17316120pubmed:monthFeblld:pubmed
pubmed-article:17316120pubmed:issn1050-7256lld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:SassolasGGlld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:PeixJ LJLlld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:BergerNNlld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:BeltranSSlld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:Borson-Chazot...lld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:ArnouxRRlld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:GiammarileFFlld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:LifanteJ CJClld:pubmed
pubmed-article:17316120pubmed:authorpubmed-author:BournaudCClld:pubmed
pubmed-article:17316120pubmed:issnTypePrintlld:pubmed
pubmed-article:17316120pubmed:volume17lld:pubmed
pubmed-article:17316120pubmed:ownerNLMlld:pubmed
pubmed-article:17316120pubmed:authorsCompleteYlld:pubmed
pubmed-article:17316120pubmed:pagination169-73lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:meshHeadingpubmed-meshheading:17316120...lld:pubmed
pubmed-article:17316120pubmed:year2007lld:pubmed
pubmed-article:17316120pubmed:articleTitleHürthle cell thyroid carcinoma metastatic to the sigmoid colon.lld:pubmed
pubmed-article:17316120pubmed:affiliationFédération d'Endocrinologie et Centre de Médecine Nucléaire, Hôpital Neurologique, Bron Cedex, France.lld:pubmed
pubmed-article:17316120pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17316120pubmed:publicationTypeCase Reportslld:pubmed